Regulation and Importance of the PI3K/Akt/mTOR Signaling Pathway in Hematologic Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|9|9|1024-1038

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.9, Iss.9, 2009-11, pp. : 1024-1038

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines

By  

Molecular Medicine Reports, Vol. 11, Iss. 2, 2015-01 ,pp. : 931-939

Spandidos Publications

Access to resources Recommend Favorite

Jolkinolide B induces apoptosis in MCF-7 cells through inhibition of the PI3K/Akt/mTOR signaling pathway

By          

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 212-218

Spandidos Publications

Access to resources Recommend Favorite

CXC195 induces apoptosis and endoplastic reticulum stress in human hepatocellular carcinoma cells by inhibiting the PI3K/Akt/mTOR signaling pathway

By            

Molecular Medicine Reports, Vol. 12, Iss. 6, 2015-01 ,pp. : 8229-8236

Spandidos Publications

Access to resources Recommend Favorite

miR125a inhibits the migration and invasion of liver cancer cells via suppression of the PI3K/AKT/mTOR signaling pathway

By          

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 681-686

Spandidos Publications

Access to resources Recommend Favorite

The PI3K/Akt Pathway as a Target in the Treatment of Hematologic Malignancies

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 5, 2009-06 ,pp. : 550-559

Bentham Science Publishers

Access to resources Recommend Favorite